Abstract
Despite research comparing adherence/persistence among long-acting injectables (LAIs) and oral antipsychotics (OAPs), a systematic synthesis of the available evidence is lacking. This study systematically reviewed real world evidence comparing LAIs and OAPs adherence/persistence among patients with schizophrenia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have